Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest — Stella

Home/Out-of-hospital Cardiac Arrest (OHCA)/

View on ClinicalTrials.gov

Recruiting

Back to Out-of-hospital Cardiac Arrest (OHCA) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Denmark

Department of Cardiology, Rigshospitalet, Copenhagen

Odense University Hospital, Odense C

Key details

Phase

Safety & dosing

Sponsor

Christian Hassager

Enrollment target

~282 participants

Started

December 2024

Primary completion

September 2027

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.